OLGA PETLINSKA: Open Payments
NPI 1164785671 · RANCHO CORDOVA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 66 payments from 18 companies in 2025. Trend: 2023 $1,513 · 2024 $1,128 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $231 |
| AstraZeneca Pharmaceuticals LP | 9 | $166 |
| ABBVIE INC. | 12 | $136 |
| Novo Nordisk Inc | 6 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Lilly USA, LLC | 3 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $43 |
Products named: AIRSUPRA, COMIRNATY, LINZESS, PREVNAR 20, Kerendia, JARDIANCE, Ozempic, MOUNJARO.
Industry payments across CA — which companies pay providers there.
